Fundz

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

PUBLIC · PYPDAug 12, 2025

Position

Chief Medical Officer

Company

PolyPid

Nurit Tweezer-Zaks
IsraelManufacturingBiotechnologyTherapeuticsBiopharma

Description

PolyPid Ltd. has announced the appointment of Dr. Nurit Tweezer-Zaks as Chief Medical Officer, effective August 18, 2025

Quick answer

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer (August 12, 2025). PolyPid is based in Israel.

Who is the new Chief Medical Officer at PolyPid?
PolyPid named Nurit Tweezer-Zaks Chief Medical Officer, announced August 12, 2025.
What did PolyPid announce on August 12, 2025?
PolyPid Ltd. has announced the appointment of Dr. Nurit Tweezer-Zaks as Chief Medical Officer, effective August 18, 2025
What does PolyPid do?
PolyPid is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes.
Where is PolyPid based?
PolyPid is based in Israel.
Which similar companies made leadership changes around the same time?
MacroGenics (August 13, 2025), CASI Pharmaceuticals (July 21, 2025), Protalix BioTherapeutics (July 21, 2025) and Jazz Pharmaceuticals plc (July 10, 2025) also announced leadership changes within 45 days of PolyPid.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at PolyPid, and when

A new leader at PolyPid brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day PolyPid raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PolyPid, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PolyPid. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PolyPid

Location

18 Hasivim Street

Israel

About

PolyPid is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the body over days to several months in a controlled manner. This allows surgeons to deliver medication right to the surgical site to improve patient outcomes in localized medical conditions such as; infection, pain, inflammation and cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PolyPid changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nurit
Senior decision-maker at this company
••••••••@••••••••

See Nurit's verified email →

Rivi
Senior decision-maker at this company
••••••••@••••••••

See Rivi's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for PolyPid's next move

Learn about Strategic plan

PolyPid changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.